Hunan Aslsen Technology (revision 24)
Old revision·18:03, 16 Jan 2025·LedgerLysander
| Hunan Aslsen Technology Co., Ltd.Organisation | |
|---|---|
Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki. | |
| Legal name | Hunan Aslsen Technology Co., Ltd. |
| Trading name | Homopeptide |
| Other designations | Homopeptide Bio, Aslsen |
| Identity | |
| Founded | Not documented |
| Headquarters | Changsha, Hunan, China |
| Industry | Research-compound supply |
| Shop domain | Visit Homopeptide |
| Products and documentation | |
| Product scope | research peptides and SARMs |
| Catalogue size | Not documented |
| Documentation | Batch certificate of analysis reported with orders |
| Independent reports | Submitted to this wiki by purchasers; see §Independent testing record |
| Organisation infobox · conventions | |
Hunan Aslsen Technology Co., Ltd. (trading as Homopeptide; homopeptide.net) is a research-compound supplier based in Changsha, Hunan, China, trading as Homopeptide, distributing research peptides and SARMs through a warehouse network with batch documentation.[1][2]
The organisation is one of twenty covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.[3]
This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.[4]
Corporate identity and history
[edit]The organisation operates from Changsha, Hunan, and trades under a designation distinct from its registered name.[1] No incorporation year is documented in sources available to this wiki and none is asserted here.
Changsha is inland, and as with the Chengdu and Xi'an entities that has consequences for transit and cold-chain exposure on China-origin shipments. Purchaser reports also describe fulfilment from regional warehouses, so the origin of a given order has not been predictable.[5]
Distribution and dispatch
[edit]The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.
Operations and documentation practice
[edit]Purchaser reports describe vialled lyophilised material with a batch certificate reporting purity and appearance. Water figures and method statements have been largely absent from the submitted set.[5][6]
Reports mention verification through several of the independent services referenced on this wiki, and the organisation's own material refers to third-party testing.[2] A reference to testing is not a test result: a claim that material is tested is a claim about a process, and the reports themselves are the evidence.[5]
Product range
[edit]| Class | Representative listings | Documentation reported |
|---|---|---|
| Incretin analogues | Semaglutide, tirzepatide | Certificate, purity only |
| Research peptides | Repair and secretagogue peptides | Certificate, purity only |
| SARMs | Bulk and capsuled | Certificate, purity |
References
- ^ a b National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.
- ^ a b Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per Project:Verifiability.
- ^ Research-use-only labelling practice; see Research use only for the legal and commercial function of the phrase.
- ^ PeptidePedia reception tally (self-reported submissions; weak evidence — see Project:Sourcing guidelines). Self-selected sample; period and count stated at each point of use.
- ^ a b c Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See Blind sampling.
- ^ United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.